WallStSmart

Lineage, Inc. Common Stock (LINE)vsRMR Group Inc (RMR)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Lineage, Inc. Common Stock generates 2347% more annual revenue ($5.36B vs $219.08M). RMR leads profitability with a 9.5% profit margin vs -2.7%. RMR earns a higher WallStSmart Score of 56/100 (C).

LINE

Avoid

34

out of 100

Grade: F

Growth: 4.0Profit: 3.0Value: 5.0Quality: 3.0
Piotroski: 2/9Altman Z: 0.67

RMR

Buy

56

out of 100

Grade: C

Growth: 2.0Profit: 6.5Value: 7.7Quality: 6.0
Piotroski: 2/9Altman Z: 2.98

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

LINE1 strengths · Avg: 10.0/10
Price/BookValuation
1.2x10/10

Reasonable price relative to book value

RMR3 strengths · Avg: 8.7/10
PEG RatioValuation
0.0910/10

Growing faster than its price suggests

P/E RatioValuation
17.2x8/10

Attractively priced relative to earnings

Price/BookValuation
1.5x8/10

Reasonable price relative to book value

Areas to Watch

LINE4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
0.4%4/10

0.4% revenue growth

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Operating MarginProfitability
3.3%3/10

Operating margin of 3.3%

Debt/EquityHealth
1.013/10

Elevated debt levels

RMR4 concerns · Avg: 2.5/10
Market CapQuality
$355.29M3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Revenue GrowthGrowth
-0.9%2/10

Revenue declined 0.9%

EPS GrowthGrowth
-76.2%2/10

Earnings declined 76.2%

Comparative Analysis Report

WallStSmart Research

Bull Case : LINE

The strongest argument for LINE centers on Price/Book.

Bull Case : RMR

The strongest argument for RMR centers on PEG Ratio, P/E Ratio, Price/Book. PEG of 0.09 suggests the stock is reasonably priced for its growth.

Bear Case : LINE

The primary concerns for LINE are Revenue Growth, EPS Growth, Operating Margin.

Bear Case : RMR

The primary concerns for RMR are Market Cap, Piotroski F-Score, Revenue Growth.

Key Dynamics to Monitor

LINE profiles as a turnaround stock while RMR is a value play — different risk/reward profiles.

LINE is growing revenue faster at 0.4% — sustainability is the question.

RMR generates stronger free cash flow (46M), providing more financial flexibility.

Monitor REIT - INDUSTRIAL industry trends, competitive dynamics, and regulatory changes.

Bottom Line

RMR scores higher overall (56/100 vs 34/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Lineage, Inc. Common Stock

REAL ESTATE · REIT - INDUSTRIAL · USA

Lineage, Inc. (Ticker: LINE) is an innovative biotechnology company specializing in regenerative medicine, with a focus on developing state-of-the-art cell therapies for conditions such as ocular diseases, spinal cord injuries, and various cancers. Leveraging its proprietary technologies and strong strategic partnerships, Lineage aims to revolutionize patient care with pioneering therapeutic solutions. The company’s dedication to advancing its diverse product pipeline and accelerating clinical trials positions it as a compelling investment prospect for institutional investors looking to engage at the cutting edge of healthcare advancements.

Visit Website →

RMR Group Inc

REAL ESTATE · REAL ESTATE SERVICES · USA

The RMR Group Inc., through its subsidiary, The RMR Group LLC, provides business and property management services in the United States. The company is headquartered in Newton, Massachusetts.

Visit Website →

Want to dig deeper into these stocks?